Cyclic peptides have been explored as ligands against a wide variety of biological targets. They are relatively easy to synthesize, and, at the same time, exhibit a degree of complexity unrivaled by most other classes of small molecules. However, cyclic peptides often suffer from poor cell permeability, a characteristic common to peptides in general. Indeed, a key bottleneck in drug development lies in the inability to predict and control factors that govern cell permeability in small molecules. The global objective of our research program is to create a new generation of biologically active, cell permeable cyclic peptides as probes and lead antibiotic and antifungal compounds. In this proposal, we seek to broaden our understanding of membrane permeability in this important class of compounds by testing hypotheses regarding the influence on backbone conformation, ring size, and side chain functionality, on the passive membrane diffusion of cyclic peptides. Taking a lesson from natural products, cell permeability in cyclic peptides is often determined by key modification - namely, N-methylation of one or more peptide amides - that help to transport the polar backbone across the hydrophobic lipid bilayer. Here we apply a powerful new approach to regioselective N-methylation to generate libraries of cyclic peptides that exhibit improved membrane permeability over their non-methylated counterparts. In addition, we will develop a strategy for the sulfenylation of cyclic and linear peptides, generating bioreversible prodrugs with greatly improved membrane permeability relative to their unmodified parent compounds. Finally, we have put in place a panel of high-throughput phenotypic screens in yeast, bacteria (V. cholera), and mammalian cells for compounds that modulate a wide variety of biological processes. Using the methods developed in the first three aims, we will generate libraries of natural product-inspired, membrane permeable cyclic peptides for input into these screens, with the end result being a collection of potent bioactive compounds poised for further development.
The overall objective of our research program is to understand the structural basis of membrane permeability in small molecules. We propose to use cyclic peptides as molecular scaffolds to study the conformational basis of permeability, and apply what we learn to create a new generation of biochemical probes. We combine computational approaches with synthetic organic chemistry and high-throughput screening to develop a new class of bioactive cyclic peptides inspired by natural products. We expect that new antibiotics and antifungal agents will emerge from this project.
|Theodore, Christine M; Lorig-Roach, Nicholas; Still, Patrick C et al. (2015) Biosynthetic products from a nearshore-derived gram-negative bacterium enable reassessment of the kailuin depsipeptides. J Nat Prod 78:441-52|
|Woehrmann, Marcos H; Bray, Walter M; Durbin, James K et al. (2013) Large-scale cytological profiling for functional analysis of bioactive compounds. Mol Biosyst 9:2604-17|
|Turner, Rushia A; Hauksson, Niels E; Gipe, Jordan H et al. (2013) Selective, on-resin N-methylation of peptide N-trifluoroacetamides. Org Lett 15:5012-5|
|Schulze, Christopher J; Bray, Walter M; Woerhmann, Marcos H et al. (2013) ""Function-first"" lead discovery: mode of action profiling of natural product libraries using image-based screening. Chem Biol 20:285-95|
|Zuckerman, Nathaniel B; Myers, Andrew S; Quan, Tiffani K et al. (2012) Structural determination of NSC 670224, synthesis of analogues and biological evaluation. ChemMedChem 7:761-5|
|White, Tina R; Renzelman, Chad M; Rand, Arthur C et al. (2011) On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nat Chem Biol 7:810-7|